scispace - formally typeset
A

Ann L. Lee

Researcher at Merck & Co.

Publications -  13
Citations -  529

Ann L. Lee is an academic researcher from Merck & Co.. The author has contributed to research in topics: Lysis & Plasmid preparation. The author has an hindex of 10, co-authored 13 publications receiving 513 citations.

Papers
More filters
Journal ArticleDOI

Gaulin Homogenization: A Mechanistic Study

TL;DR: The results indicate that breakage occurs primarily by fluid shear, although a contribution by cavitation is also apparent when back pressure is applied, and a thorough evaluation of the impact of free radicals in upstream homogenization is warranted.
Journal ArticleDOI

Fractional precipitation of plasmid DNA from lysate by CTAB.

TL;DR: It is shown herein that precipitation with the cationic detergent, cetyltrimethylammonium bromide (CTAB), is effective for selective precipitation of plasmid DNA from proteins, RNA, and endotoxin and affords novel selectivity by removal of host genomic DNA and even the more closely related relaxed and denatured forms ofplasmid as earlier, separate fractions.
Patent

Methods of adenovirus purification

TL;DR: In this article, a process for purifying virus particles, especially recombinant adenovirus vector particles, is presented, which relies on various combinations of cell lysis, detergent-based precipitation of host cell contaminants away from the virus, depth filtration or centrifugation, ultrafiltration, nuclease digestion and chromatography to robustly and economically produce highly purified product.
Journal ArticleDOI

Development of a novel adenovirus purification process utilizing selective precipitation of cellular DNA.

TL;DR: An adenovirus purification process was developed which incorporates selective precipitation of host cell DNA, enabling a reduction in the use of costly nucleases and chromatographic resins while substantially improving DNA and protein clearance capabilities.
Patent

A method for large scale plasmid purification

TL;DR: In this article, a process for the large scale isolation and purification of plasmid DNA from large scale microbial fermentations is disclosed, which is suitable for inclusion in a pharmaceutical composition.